Natural killer cells modulate overt autoimmunity to homeostasis in nonobese diabetic mice after anti-CD3 F(ab′)2 antibody treatment through secreting transforming growth factor-β

American Journal of Pathology

Volumn 175, Issue 3, 2009, Pages 1086-1094

  Chen, Guojiang ^a   Han, Gencheng ^a   Wang, Jianan ^a   Wang, Renxi ^a   Xu, Ruonan ^a   Shen, Beifen ^a   Qian, Jiahua ^b   Li, Yan ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE HOMEOSTASIS; LYMPH NODE; MOUSE; NATURAL KILLER CELL; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS; PHENOTYPE; PRIORITY JOURNAL; SEVERE COMBINED IMMUNODEFICIENCY; SPLEEN; TH2 CELL;

EID: 70349232341     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080488     Document Type: Article

References (43)

1. Cameron MJ, Meagher C, Delovitch TL: Failure in immune regulation begets IDDM in NOD mice. Diabetes Metab Rev 1998, 14:177-185 (Pubitemid 28346264)
2. Chatenoud L, Thervet E, Primo J, Bach JF: Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci USA 1994, 91:123-127 (Pubitemid 24018655)
3. Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, Gorus F, Goldman M, Walter M, Candon S, Schandene L, Crenier L, De Block C, Seigneurin JM, De Pauw P, Pierard D, Weets I, Rebello P, Bird P, Berrie E, Frewin M, Waldmann H, Bach JF, Pipeleers D, Chatenoud L: Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005, 352:2598-2608 (Pubitemid 41007846)
4. Herold KC, Gitelman SE, Masharani U, Hagopian W, Bisikirska B, Donaldson D, Rother K, Diamond B, Harlan DM, Bluestone JA: A single course of anti-CD3 monoclonal antibody hOKT3γ1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 2005, 54:1763-1769 (Pubitemid 40770766)
5. 2 treatment reversed new onset diabetes in NOD mice. Am J Pathol 2008, 172:972-979
6. + regulatory T cells. J Leukoc Biol 2008, 83:280-287
7. Trinchieri G: Biology of natural killer cells. Adv Immuol 1989, 47:187-376
8. Kos FJ: Regulation of adaptive immmunity by natural killer cells. Immunol Res 1998, 17:303-312 (Pubitemid 28302188)
9. Kelly JM, Takeda K, Darcy PK, Yagita H, Smith MJ: A role of IFN-γ in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo. J Immunol 2002, 168:4472-4479 (Pubitemid 34441349)
10. Poulton LD, Smyth MJ, Hawke CG, Silveira P, Shepherd D, Naidenko OV, Godfrey DI, Baxter AG: Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int Immunol 2001, 13:887-896 (Pubitemid 32685201)
11. Johansson SE, Hall H, Björklund J, Höglund P: Broadly impaired NK cell function in nonobese diabetic mice is partially restored by NK cell activation in vivo and by IL-12/IL-18 in vitro. Int Immunol 2004, 16:1-11 (Pubitemid 38054621)
12. Zhou R, Wei H, Tian Z: NK3-like NK cells are involved in protective effect of polyinosinic-polycytidylic acid on type 1 diabetes in nonobese diabetic mice. J Immunol 2007, 178:2141-2147 (Pubitemid 46233411)
13. Belghith M, Bluestone JA, Barriot S, Megret J, Bach JF, Chatenoud L: TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 2003, 9:1202-1208 (Pubitemid 37173706)
14. + T cells through TGF-β-TGF-β receptor interactions in type 1 diabetes. Proc Natl Acad Sci USA 2003, 100:10878-10883
15. Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H, Strober W: TGF-β1 play an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol 2004, 172:834-842 (Pubitemid 38113739)
16. Horwitz DA, Gray JD, Ohtsuka K: Role of NK cells and TGF-β in the regulation of T-cell-dependent antibody production in health and autoimmune disease. Microbes Infect 1999, 1:1305-1311
17. Gray JD, Hirokawa M, Ohtsuka K, Horwitz DA: Generation of an inhibitory circuit involving CD8+ T cells. IL-2, and NK cell-derived TGF-β: contrasting effects of anti-CD2 and anti-CD3. J Immunol 1998, 160:2248-2254 (Pubitemid 28119905)
18. Brunda MJ: Interleukin-12. J Leukoc Biol 1994, 55:280-288
19. Xia Z, Xu L, Zhong W, Wei J, Li N, Shao J, Li Y, Yu S, Zhang Z: Heme oxygenase-1 attenuates ovalbumin-induced airway inflammation by up-regulation of Foxp3 T-regulatory cells, interleukin-10, and membrane-bound transforming growth factor-β1. Am J Pathol 2007, 171:1904-1914
20. Ostroukhova M, Qi Z, Oriss TB, Dixon-McCarthy B, Ray P, Ray A: Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-β. J Clin Invest 2006, 116:996-1004
21. Ostroukhova M, Segiun-Devaux C, Oriss TB, Dixon-McCarthy B, Yang L, Ameredes BT, Corcoran TE, Ray A: Tolerance induced by inhaled antigen involves CD4+ T cells expressing membrane-bound TGF-β and FOXP3. J Clin Invest 2004, 114:28-38 (Pubitemid 39071641)
22. Lanier LL: Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 2008, 9:495-502 (Pubitemid 351560518)
23. Ogasawara K, Hamerman JA, Hsin H, Chikuma S, Bour-Jordan H, Chen T, Pertel T, Carnaud C, Bluestone JA, Lanier LL: Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 2003, 18:41-51 (Pubitemid 36120686)
24. Homann D, Jahreis A, Wolfe T, Hughes A, Coon B, van Stipdonk MJ, Prilliman KR, Schoenberger SP, von Herrath MG: CD40L blockade prevents autoimmune diabetes by induction of bitype NK/DC regulatory cells. Immunity 2002, 16:403-415 (Pubitemid 34260918)
25. Kim J, Richter W, Aanstoot H-J, Shi Y, Fu Q, Rajotte R, Warnock G, Baekkeskov S: Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets. Diabetes 1993, 42:1799-1808 (Pubitemid 23346417)
26. Lernmark A, Agardh CD: Immunomodulation with human recombinant autoantigens. Trends Immunol 2005, 26:608-612
27. Terabe M, Matsui S, Park JM, Mamura M, Noben-Trauth N, Donaldson DD, Chen W, Wahl SM, Ledbetter S, Pratt B, Letterio JJ, Paul WE, Berzofsky JA: Transforming growth factor-β production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J Exp Med 2003, 198:1741-1752 (Pubitemid 37494166)
28. Tran GT, Carter N, He XY, Spicer TS, Plain KM, Nicolls M, Hall BM, Hodgkinson SJ: Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T(h)1 cells that is augmented by IL-4. Int Immunol 2001, 13:1109-1120 (Pubitemid 32899153)
29. Utset TO, Auger JA, Peace D, Zivin RA, Xu D, Jolliffe L, Alegre ML, Bluestone JA, Clark MR: Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial. J Rheumatol 2002, 29:1907-1913 (Pubitemid 34988699)
30. Steffens S, Burger F, Pelli G, Dean Y, Elson G, Kosco-Vilbois M, Chatenoud L, Mach F: Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice. Circulation 2006, 114:1977-1984 (Pubitemid 44665393)
31. Johansson S, Berg L, Hall H, Hoglund P: NK cells: elusive players in autoimmunity. Trends Immunol 2005, 26:613-618
32. Poirot L, Benoist C, Mathis D: Natural killer cells distinguish inncuous and destructive forms of pancreatic islet autoimmunity. Proc Natl Acad Sci USA 2004, 101:8102-8107 (Pubitemid 38698061)
33. Lee IF, Qin H, Trudeau J, Dutz J, Tan R: Regulation of autoimmune diabetes by complete Freund's adjuvant is mediated by NK cells. J Immunol 2004, 172:937-942 (Pubitemid 38113752)
34. Zhang B, Yamamura T, Kondo T, Fujiwara M, Tabira T: Regulation of experimental autoimmune encephalomyelitisby natural killer (NK) cells. J Exp Med 1997, 186:1677-1687 (Pubitemid 27506281)
35. Shi FD, Takeda K, Akira S, Sarventick N, Ljunggren HG: IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-γ by NK cells. J Immunol 2000, 165:3099-3104 (Pubitemid 30728162)
36. Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA: Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 1996, 98:70-77 (Pubitemid 26243822)
37. Li MO, Wan YY, Sanjabi S, Robertson AL, Flavell RA: Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 2006, 24:99-146
38. Smeltz RB, Wolf NA, Swanborg RH: Inhibition of autoimmune T cell responses in the DA rat by bone marrow-derived NK cells in vitro: implications for autoimmunity. J Immunol 1999, 163:1390-1397
39. Chatenoud L, Primo J, Bach JF: CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J Immunol 1997, 158:2947-2954 (Pubitemid 127470558)
40. + T lymphocytes. Inhibition by transforming growth factor-β. J Immunol 1991, 146:3289-3297
41. Bach JF, Bendelac A, Brenner MB, Cantor H, De Libero G, Kronenberg M, Lanier LL, Raulet DH, Shlomchik MJ, von Herrath MG: The role of innate immunity in autoimmunity. J Exp Med 2004, 200:1527-1531
42. + regulatory T cells, restores self-tolerance, and facilitates regeneration of β cell function in overtly diabetic nonobese diabetic mice. Transplantation 2005, 79:1091-1096
43. - T lymphocytes. Exp Hematol 2007, 35:416-425